163 related articles for article (PubMed ID: 7904635)
41. Pharmacological evaluation of N-methyl-actinodaphnine, a new vascular alpha-adrenoceptor antagonist, isolated from Illigera luzonensis.
Guh JH; Ko FN; Yu SM; Wu YC; Teng CM
Eur J Pharmacol; 1995 Jun; 279(1):33-41. PubMed ID: 7556380
[TBL] [Abstract][Full Text] [Related]
42. Binding and functional characterization of alpha1-adrenoceptor subtypes in the rat prostate.
Hiraoka Y; Ohmura T; Oshita M; Watanabe Y; Morikawa K; Nagata O; Kato H; Taniguchi T; Muramatsu I
Eur J Pharmacol; 1999 Jan; 366(1):119-26. PubMed ID: 10064160
[TBL] [Abstract][Full Text] [Related]
43. Effects of castration on contraction and alpha(1)-adrenoceptor expression in rat prostate.
Homma Y; Hamada K; Nakayama Y; Tsujimoto G; Kawabe K
Br J Pharmacol; 2000 Dec; 131(7):1454-60. PubMed ID: 11090120
[TBL] [Abstract][Full Text] [Related]
44. Radioligand binding studies of alpha 1-adrenoceptor subtypes in rat heart.
Michel MC; Hanft G; Gross G
Br J Pharmacol; 1994 Feb; 111(2):533-8. PubMed ID: 7911718
[TBL] [Abstract][Full Text] [Related]
45. Characterization of some novel alpha 1-adrenoceptor antagonists in human hyperplastic prostate.
Chueh SC; Chern JW; Choong CM; Guh JH; Teng CM
Eur J Pharmacol; 2002 Jun; 445(1-2):125-31. PubMed ID: 12065203
[TBL] [Abstract][Full Text] [Related]
46. Effect of cyproterone acetate on alpha1-adrenoceptor subtypes in rat vas deferens.
Campos M; Morais PL; Pupo AS
Braz J Med Biol Res; 2003 Nov; 36(11):1571-81. PubMed ID: 14576912
[TBL] [Abstract][Full Text] [Related]
47. Sympathetic neurotransmission in the rat testicular capsule: functional characterization and identification of mRNA encoding alpha1-adrenoceptor subtypes.
Jurkiewicz NH; Caricati-Neto A; Verde LF; Avellar MC; Reuter HR; Jurkiewicz A
Eur J Pharmacol; 2006 Aug; 543(1-3):141-50. PubMed ID: 16822496
[TBL] [Abstract][Full Text] [Related]
48. Functional evidence for an alpha 1B-adrenoceptor mediating contraction of the mouse spleen.
Eltze M
Eur J Pharmacol; 1996 Sep; 311(2-3):187-98. PubMed ID: 8891599
[TBL] [Abstract][Full Text] [Related]
49. Investigation of the subtypes of alpha1-adrenoceptor mediating contractions of rat vas deferens.
Honner V; Docherty JR
Br J Pharmacol; 1999 Nov; 128(6):1323-31. PubMed ID: 10578148
[TBL] [Abstract][Full Text] [Related]
50. Alpha 1A-adrenoceptors in rabbit bronchus.
Takayanagi I; Moriya M
Eur J Pharmacol; 1991 Sep; 202(2):281-3. PubMed ID: 1687033
[TBL] [Abstract][Full Text] [Related]
51. Different sites of action for alpha 2-adrenoceptor antagonists in the modulation of noradrenaline release and contraction response in the vas deferens of the rat.
Harsing LG; Vizi ES
J Pharm Pharmacol; 1992 Mar; 44(3):231-4. PubMed ID: 1354730
[TBL] [Abstract][Full Text] [Related]
52. Functional characterization of alpha1-adrenoceptor subtypes in longitudinal and circular muscle of human vas deferens.
Amobi N; Guillebaud J; Coker C; Mulvin D; Smith IC
Eur J Pharmacol; 1999 Feb; 367(2-3):291-8. PubMed ID: 10079004
[TBL] [Abstract][Full Text] [Related]
53. Failure of AH11110A to functionally discriminate between alpha(1)-adrenoceptor subtypes A, B and D or between alpha(1)- and alpha(2)-adrenoceptors.
Eltze M; König H; Ullrich B; Grebe T
Eur J Pharmacol; 2001 Mar; 415(2-3):265-76. PubMed ID: 11275009
[TBL] [Abstract][Full Text] [Related]
54. Role of intracellular Ca2+ stores in smooth muscle contractions of the guinea pig vas deferens.
Drescher P; Eckert RE; Madsen PO
Urol Res; 1993; 21(5):319-23. PubMed ID: 7506463
[TBL] [Abstract][Full Text] [Related]
55. Functional and radioligand binding characterization of the α1L-adrenoceptor subtype of the human vas deferens.
Davis BJ; Wiener M; Chapple CR; Sellers DJ; Chess-Williams R
Auton Autacoid Pharmacol; 2015 Apr; 34(3-4):41-9. PubMed ID: 25790239
[TBL] [Abstract][Full Text] [Related]
56. Alpha 1-adrenoceptors and calcium sources in adrenergic neurogenic contractions of rat vas deferens.
Bültmann R; Kurz AK; Starke K
Br J Pharmacol; 1994 Jan; 111(1):151-8. PubMed ID: 7912153
[TBL] [Abstract][Full Text] [Related]
57. The receptor antagonist picotamide inhibits adrenergic and thromboxane-induced contraction of hyperplastic human prostate smooth muscle.
Hennenberg M; Miljak M; Herrmann D; Strittmatter F; Walther S; Rutz B; Hocaoglu Y; Kunit T; Schreiber A; Andersson KE; Stief CG; Gratzke C
Am J Physiol Renal Physiol; 2013 Nov; 305(10):F1383-90. PubMed ID: 24049147
[TBL] [Abstract][Full Text] [Related]
58. Investigation of the effects of some alkaloidal alpha1-adrenoceptor antagonists on human hyperplastic prostate.
Guh JH; Hsieh CH; Teng CM
Eur J Pharmacol; 1999 Jun; 374(3):503-10. PubMed ID: 10422796
[TBL] [Abstract][Full Text] [Related]
59. Investigation of the actions of chloroethylclonidine in rat aorta.
O'Rourke M; Kearns S; Docherty JR
Br J Pharmacol; 1995 Aug; 115(8):1399-406. PubMed ID: 8564198
[TBL] [Abstract][Full Text] [Related]
60. Mirabegron relaxes urethral smooth muscle by a dual mechanism involving β3 -adrenoceptor activation and α1 -adrenoceptor blockade.
Alexandre EC; Kiguti LR; Calmasini FB; Silva FH; da Silva KP; Ferreira R; Ribeiro CA; Mónica FZ; Pupo AS; Antunes E
Br J Pharmacol; 2016 Feb; 173(3):415-28. PubMed ID: 26493129
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
